NCCN Conference Highlights

Genomic Instability Score Predicts Survival in Patients with Ovarian Cancer

Genomic Instability Score Predicts Survival in Patients with Ovarian Cancer

May 2016, Vol 7, No 4 - NCCN Conference Highlights

A higher score on a composite index of homologous recombination deficiency (HRD), indicating genomic instability, correlated with improved progression-free survival (PFS) and overall survival (OS) in patients with ovarian cancer who have received platinum-containing chemotherapy, according to results presented at [ Read More ]